FDA Dose Content Uniformity Standards Could Be Replaced By IPAC Proposal
FDA dose content uniformity standards could be replaced by IPAC-RS standards, the agency said during the Pharmaceutical Science Advisory Committee meeting March 13
You may also be interested in...
Acceptance criteria for dose content uniformity in FDA's metered-dose inhaler guidance is too restrictive, Glaxo Wellcome and other MDI manufacturers asserted in comments to the agency.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials